Evidence mapPaperPMID 42018264Full record

ArticleMolecular and cellular pediatrics2026

Protein-truncating variants in APBA1 in minors with severe, early-onset obesity: implications for genetic testing.

Joanna Lerner, Abubakar Moawia, Stefanie Zorn, Simone Kloker, Margit Klehr-Martinelli, Kay Winner, Denisa Penfold, Thomas M K Völkl, Miriam Krausnick, Reiner Siebert and 1 more

Abstract read
In one paragraph

Article in Molecular and cellular pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joanna Lerner *Institute of Human Genetics, Ulm University Medical Centre, Ulm, Germany.
Abubakar Moawia *Institute of Human Genetics, Ulm University Medical Centre, Ulm, Germany.
Stefanie ZornDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Centre, Ulm, Germany.
Simone KlokerInstitute of Human Genetics, Ulm University Medical Centre, Ulm, Germany.
Margit Klehr-MartinelliInstitute of Human Genetics, Ulm University Medical Centre, Ulm, Germany.
Kay WinnerDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Centre, Ulm, Germany.
Denisa PenfoldDivision of Pediatric Endocrinology and Diabetology, Department of Pediatric and Adolescent Medicine, KJF Klinikum Josefinum, Augsburg, Germany.
Thomas M K VölklDivision of Pediatric Endocrinology and Diabetology, Department of Pediatric and Adolescent Medicine, KJF Klinikum Josefinum, Augsburg, Germany.
Miriam KrausnickPediatric Endocrinology, Endokrinologikum München, Munich, Germany.
Reiner SiebertInstitute of Human Genetics, Ulm University Medical Centre, Ulm, Germany.
Martin WabitschCentre for Rare Diseases, Ulm University Medical Centre, Ulm, Germany. martin.wabitsch@uniklinik-ulm.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere, early-onset obesity is a monogenic disorder in a subset of patients. Recently, rare protein-truncating variants (PTVs) in BSN and APBA1 have been implicated as monogenic causes of obesity. Truncating variants in these two genes have been associated with adult-onset monogenic obesity. Here, we aimed to investigate the occurrence of rare PTVs in APBA1 and BSN in minors with severe obesity manifesting in early childhood or adolescence.

methodsPreviously obtained exome data of 209 children and adolescents (0–18 years) with severe obesity manifesting in early childhood or adolescence genetically tested at the Ulm University Medical Center between April 2022 and May 2024 were mined for rare PTVs in APBA1 (NM_ 001163.4; NP_ NP_001154.2) and BSN (NM_003458.4; NP_003449.2). In all patients, monoallelic, and in the case of autosomal-recessive inheritance, biallelic likely pathogenic and pathogenic variants in well-known obesity-associated genes were excluded. Clinical re-evaluation was performed in two identified cases with rare potentially protein-truncating variants in APBA1.

resultsThe first patient (male, 15 years) presented with a BMI of 33.7 kg/m2 (BMI z-score: 2.7) after nine years of excessive weight gain despite life-style interventions. He had a body fat percentage of 49.5% and showed hyperphagia. The patient displayed impaired expressive language development, dyslexia and an IQ of 84. His mother also had obesity and dyslexia while his father and younger sister were unaffected. We identified the heterozygous, likely pathogenic variant APBA1:c.814C > T;p.(Gln272*) in the index patient and his mother. The second patient (male, 6 years) presented with a BMI of 30.0 kg/m2 (BMI z-score: 3.8), a body fat percentage of 43.6% and hyperphagia. The child had upslanting palpebral fissures and showed impaired expressive language development. Both parents of the boy were affected by severe obesity and underwent bariatric surgery. We identified the heterozygous variant of unknown significance APBA1:c.2442 + 3A > C predicted to impair proper splicing in the index patient and his mother.

conclusionWe conclude that rare potentially protein-truncating variants in APBA1 are also found in some minors with early-onset and severe obesity. Therefore, those variants might not be restricted to adult-onset disease. We therefore propose to include APBA1 in diagnostic genetic testing for monogenic obesity in minors and adults.

Indexed as

APBA1Genetic TestingHyperphagiaObesity

Identifiers

PMID42018264
PMCPMC13103126

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.